Megaphone Eyewire headlines are now available as a weekly podcast! Listen Now

Now Playing

Eyewire TV November 30, 2022 thumbnail

Introduction

story 1 thumbnail

Aldeyra Therapeutics Submits NDA for Reproxalap for Signs and Symptoms of DED

story 2 thumbnail

Alcon Completes Acquisition of Aerie Pharmaceuticals

story 3 thumbnail

Kala Submits Investigational NDA for KPI-012 for the Treatment of Rare Corneal Defect


Previous EyewireTV Episodes